Lyell Immunopharma (LYEL) Prepaid Assets (2020 - 2026)

Lyell Immunopharma has reported Prepaid Assets for 7 years, with the latest figure at $13.3 million in Q1 2026.

• Quarterly Prepaid Assets rose 65.99% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 65.99% YoY) and the FY2025 annual result came in at $13.7 million, up 51.31% from the prior year.
• Prepaid Assets declined to $13.3 million in Q1 2026 per LYEL's latest filing, from $13.7 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $13.7 million in Q4 2025 and troughed at $5.4 million in Q2 2025.
• A 5-year average of $10.1 million and a median of $10.7 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2025 and 2026: Prepaid Assets slumped 37.69% in 2025, then jumped 65.99% in 2026.
• Over 5 years, Prepaid Assets stood at $11.1 million in 2022, then retreated by 24.05% to $8.5 million in 2023, then rose by 7.14% to $9.1 million in 2024, then surged by 51.31% to $13.7 million in 2025, then fell by 3.19% to $13.3 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $13.3 million, $13.7 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.